Metraipolis › archive › dc_0981f7487eab

Case Report: Personalized therapy in gynecological neuroendocrine neoplasm: a case of BRCA2-mutated ovarian neuroendocrine carcinoma treated with PARP-inhibitor — Europe PMC PMID:42614412

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42614412
DOI
10.3389/fonc.2026.1774835
License (as archived)
solo-consultazione
Archived
2026-10-17T04:08:04.821Z
SHA-256 of the archived text
0e40462dcb7cccf8c3f761fea8178fd6433ab6094e2b5362d941c8ecca9fec10
Stable URL of this page
https://metraipolis.com/documento/dc_0981f7487eab

How to cite

Case Report: Personalized therapy in gynecological neuroendocrine neoplasm: a case of BRCA2-mutated ovarian neuroendocrine carcinoma treated with PARP-inhibitor — Europe PMC PMID:42614412 — Europe PMC (en), https://europepmc.org/article/MED/42614412 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0981f7487eab (Metraipolis archive dc_0981f7487eab, sha256 0e40462dcb7cccf8c3f761fea8178fd6433ab6094e2b5362d941c8ecca9fec10)
BibTeX
@misc{dc0981f7487eab,
  title = {Case Report: Personalized therapy in gynecological neuroendocrine neoplasm: a case of BRCA2-mutated ovarian neuroendocrine carcinoma treated with PARP-inhibitor — Europe PMC PMID:42614412},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42614412},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0981f7487eab; sha256 0e40462dcb7cccf8c3f761fea8178fd6433ab6094e2b5362d941c8ecca9fec10},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42614412. Agents can read the archived copy with the MCP tool read_document.